Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
José A MatamorosRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0003-0607-5225
Sara Rubio-CasadoRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0002-2020-2721
José A Fernández-AlbarralRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0003-0399-7996
Miguel A Martínez-LópezRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0001-7481-2536
Ana I RamírezRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0002-2656-4723
Elena Salobrar-GarcíaRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0001-5939-5551
Eva M MarcoRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.
Victor Paleo-GarcíaDepartment of Physiology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
Rosa de HozRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0002-1581-087X
Inés López-CuencaRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0003-0511-515X
Lorena Elvira-HurtadoRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0003-0300-2602
Lidia Sánchez-PueblaRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0002-4430-8782
José M RamírezRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0002-5145-5094
Meritxell López-GallardoRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0002-9291-623X
Juan J SalazarRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid (ROR 02p0gd045), 28040 Madrid, Spain.ORCID 0000-0001-5480-5902
Funding
This research was funded by Article 83: 4158788 (UCM-VISUfarma Spain.). J.A.M. is currently supported by a predoctoral fellowship (CT58/21-CT59/21) from the Complutense University of Madrid. S.R.-C. is currently supported by a predoctoral fellowship (CT15 This research was funded by Article 83: 4158788 (UCM-VISUfarma Spain.). J.A.M. is currently supported by a predoctoral fellowship (CT58/21-CT59/21) from the Complutense University of Madrid. S.R.-C. is currently supported by a predoctoral fellowship (CT15
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Citicoline and Coenzyme Q10: Therapeutic Agents for Glial Activation Reduction in Ocular Hypertension. · full record | Socratic